A

Avadel Pharmaceuticals plc
D

AVDL

10.310
USD
-0.41
(-3.82%)
مغلق
حجم التداول
43,848
الربح لكل سهم
-0
العائد الربحي
-
P/E
-14
حجم السوق
993,487,354
أصول ذات صلة
    A
    AGIO
    -3.005
    (-7.16%)
    38.990 USD
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    B
    BPMC
    -4.690
    (-4.86%)
    91.790 USD
    E
    EXEL
    -0.970
    (-2.80%)
    33.690 USD
    G
    GTHX
    0.01000
    (0.14%)
    7.16000 USD
    I
    INCY
    -1.820
    (-2.62%)
    67.550 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    P
    PBYI
    -0.14500
    (-4.97%)
    2.77000 USD
    المزيد
الأخبار

العنوان: Avadel Pharmaceuticals plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.